Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1831 AL 1845

Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems

Daraban BS, Popa AS, Stan MS.

Molecules. 2024 Aug 27;29(17):4056. doi: 10.3390/molecules29174056.

Visual assessments of 11 C-Pittsburgh compound-B PET vs. 18 F-flutemetamol PET across the age spectrum

Zeydan B, Johnson DR, Schwarz CG, Przybelski SA, Lesnick TG, Senjem ML, Kantarci OH, Min PH, Kemp BJ, Jack CR Jr, Kantarci K, Lowe VJ.

Nucl Med Commun. 2024 Dec 1;45(12):1047-1054. doi: 10.1097/MNM.0000000000001902. Epub 2024 Sep 13.

Effects of a nurse-led staged integral art-based cognitive intervention for older adults on the Alzheimer's disease spectrum: A randomized controlled trial

Yan Y, Huang C, Lin R, Chen M, Wang Y, Xu Y, Chao Y, Zhang C, Sun W, Wang N, Ye Y, Lin M, Li H.

Int J Nurs Stud. 2024 Dec;160:104902. doi: 10.1016/j.ijnurstu.2024.104902. Epub 2024 Sep 7.

New insights into innate immunity in Alzheimer's disease: from APOE protective variants to therapies

Chen Y, Holtzman DM.

Trends Immunol. 2024 Oct;45(10):768-782. doi: 10.1016/j.it.2024.08.001. Epub 2024 Sep 14.

Multifunctional Tasks and an Energy Crisis are Crucial Players in Determining the Vulnerability of the Entorhinal Cortex to Early Damage in Alzheimer's Disease

Sivanesan S, Howell MD, Kaushik V, Jayakumar R, Pari SM, Goyal P.

Curr Alzheimer Res. 2024;21(5):295-311. doi: 10.2174/0115672050324909240823104209.

Clinical Update on an Anti-Alzheimer Drug Candidate CT1812: A Sigma-2 Receptor Antagonist

Kaur G, Dar ZA, Bajpai A, Singh R, Bansal R.

Clin Ther. 2024 Nov;46(11):e21-e28. doi: 10.1016/j.clinthera.2024.08.013. Epub 2024 Sep 16.

Genetic overlap between schizophrenia spectrum disorders and Alzheimer's disease: Current evidence and future directions - An integrative review

Ohi K, Fujikane D, Shioiri T.

Neurosci Biobehav Rev. 2024 Dec;167:105900. doi: 10.1016/j.neubiorev.2024.105900. Epub 2024 Sep 17.

Validation of a Simplified Tissue-to-Reference Ratio Measurement Using SUVR to Assess Synaptic Density Alterations in Alzheimer Disease with [(11)C]UCB-J PET

Young JJ, O'Dell RS, Naganawa M, Toyonaga T, Chen MK, Nabulsi NB, Huang Y, Cooper E, Miller A, Lam J, Bates K, Ruan A, Nelsen K, Salardini E, Carson RE, van Dyck CH, Mecca AP.

J Nucl Med. 2024 Nov 1;65(11):1782-1785. doi: 10.2967/jnumed.124.267419.

Past, Present, and Future of Liver-Brain Axis in Alzheimer's Disease: A Bibliometric Review

Liu XL, Yeerlan J, Liu Z, Bai Y, Wang Q, Yan Y, Xu L, Jia C, Zhang L.

J Alzheimers Dis. 2024;101(4):1267-1280. doi: 10.3233/JAD-240688.

Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations

Wang J, Fourriere L, Gleeson PA.

Biochem J. 2024 Oct 2;481(19):1297-1325. doi: 10.1042/BCJ20240056.

Navigating the roads ahead for Alzheimer's disease

Stirrups R.

Lancet Neurol. 2024 Oct;23(10):971. doi: 10.1016/S1474-4422(24)00374-0.

Current pharmacophore based approaches for the development of new anti-Alzheimer's agents

Sharma P, Sharma S, Yadav Y, Shukla P, Sagar R.

Bioorg Med Chem. 2024 Nov 1;113:117926. doi: 10.1016/j.bmc.2024.117926. Epub 2024 Sep 13.

The multiple roles of chronic stress and glucocorticoids in Alzheimer's disease pathogenesis

Burke MR, Sotiropoulos I, Waites CL.

Trends Neurosci. 2024 Nov;47(11):933-948. doi: 10.1016/j.tins.2024.08.015. Epub 2024 Sep 21.

REAL AD-Validation of a realistic screening approach for early Alzheimer's disease

Leuzy A, Heeman F, Bosch I, Lenér F, Dottori M, Quitz K, Moscoso A, Kern S, Zetterberg H, Blennow K, Schöll M.

Alzheimers Dement. 2024 Nov;20(11):8172-8182. doi: 10.1002/alz.14219. Epub 2024 Sep 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias